Impact of lymph node metastases on outcome following treatment with sorafenib in patients with hepatocellular carcinoma (HCC): Subset analysis from the phase III SHARP trial

被引：0

作者：

Raoul, J.

Craxi, A.

Porta, C.

Lentini, G.

Nadel, A.

Voliotis, D.

Bruix, J.

Llovet, J. M.

机构：

[1] Ctr Eugene Marquis, Rennes, France

[2] Azienda Osped Univ, Palermo, Italy

[3] San Matteo Univ Hosp, IRCCS, Pavia, Italy

[4] Bayer Vital GmbH, Leverkusen, Germany

[5] Bayer HealthCare Pharmaceut, Montville, NJ USA

[6] Hosp Clin Barcelona, Barcelona, Spain

[7] Mt Sinai Sch Med, New York, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e15547

引用

页数：2